Drug-induced liver injury: a real-world pharmacovigilance study using the FDA adverse event reporting system database 2004-2024
database[Title] 2025-11-22
Summary:
CONCLUSIONS: Our study summarized a reported culprit-drug list of DILI by comprehensively reviewing the liver injury-related reports in the FAERS database, and highlighted the prominent position of antineoplastic agents in reporting frequency, risk signal strength ranking, number of positive signal drugs, and high-risk drug distribution, suggesting that we may need to pay more attention to the liver injury risk of antineoplastic agents in clinical practice.